01 PHYTON BIOTECH LLC Delta CA (2)
02 SERIPHARM S.A.S. Le Mans FR (1)
03 CHONGQING SINTAHO PHARMACEUTICAL CO., LTD. Maliuzui CN (1)
04 APITORIA PHARMA PRIVATE LIMITED Hyderabad IN (1)
05 CENWAY PHARMACEUTICALS CO., LTD. Tianjin CN (1)
06 CORDEN PHARMA BOULDER, INC. Boulder US (1)
07 FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN (1)
08 Fujian South Pharmaceutical Co., Ltd. Sanming City CN (1)
09 HETERO LABS LIMITED Hyderabad IN (1)
10 INDENA S.P.A. Milano IT (4)
11 INTAS PHARMACEUTICALS LIMITED Ahmedabad IN (2)
12 MSN LABORATORIES PRIVATE LIMITED Kardanur Village IN (1)
13 POLYMED THERAPEUTICS, INC. Houston US (2)
14 SAMYANG BIOPHARMACEUTICALS CORPORATION Daejeon KR (1)
15 SAMYANG HOLDINGS CORPORATION Gyeonggi-do KR (1)
16 SCINOPHARM TAIWAN, LTD. Shan-Hua TW (2)
17 TAIHUA NATURAL PLANT PHARMACEUTICAL CO., LTD. Shangzhou CN (1)
18 TEVA CZECH INDUSTRIES S.R.O. Opava CZ (1)
19 TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL (1)
20 WUHAN CALMLAND PHARMACEUTICALS CO., LTD. Wuhan CN (1)
21 YUNNAN HANDE BIO-TECH CO., LTD. Kunming CN (1)
22 YUNNAN HANDE BIO-TECH CO., LTD. Taiping Town CN (1)
01 Paclitaxel, Isolated from natural source: whole plant of Taxus x media (1)
02 Paclitaxel, Isolated from natural sources (4)
03 Paclitaxel, Produced by a semi-synthetic process (10)
04 Paclitaxel, Produced by a semi-synthetic process – Process II (2)
05 Paclitaxel, Produced by a semi-synthetic process, product code SPT 1308 (1)
06 Paclitaxel, Produced by fermentation (2)
07 Paclitaxel, Produced by semi-synthetic process (3)
08 Paclitaxel, Semi synthetic process (1)
09 Paclitaxel, Semi-synthetic process (1)
10 Paclitaxel, isolated from natural source: roots of Taxus x media (1)
11 Paclitaxel, isolated from natural sources (1)
12 Paclitaxel, produced by a semi-synthetic process (1)
13 Paclitaxel, produced by semi-synthetic process (1)
01 Canada (2)
02 China (7)
03 France (1)
04 Germany (1)
05 India (6)
06 Israel (2)
07 Italy (4)
08 South Korea (2)
09 Taiwan (2)
10 U.S.A (2)
01 Expired (1)
02 Valid (25)
03 Withdrawn by EDQM Failure to CEP procedure (1)
04 Withdrawn by Holder (2)
91
PharmaCompass offers a list of Paclitaxel API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Paclitaxel manufacturer or Paclitaxel supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Paclitaxel manufacturer or Paclitaxel supplier.
PharmaCompass also assists you with knowing the Paclitaxel API Price utilized in the formulation of products. Paclitaxel API Price is not always fixed or binding as the Paclitaxel Price is obtained through a variety of data sources. The Paclitaxel Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NCGC00024995-02 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NCGC00024995-02, including repackagers and relabelers. The FDA regulates NCGC00024995-02 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NCGC00024995-02 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NCGC00024995-02 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A NCGC00024995-02 supplier is an individual or a company that provides NCGC00024995-02 active pharmaceutical ingredient (API) or NCGC00024995-02 finished formulations upon request. The NCGC00024995-02 suppliers may include NCGC00024995-02 API manufacturers, exporters, distributors and traders.
click here to find a list of NCGC00024995-02 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A NCGC00024995-02 CEP of the European Pharmacopoeia monograph is often referred to as a NCGC00024995-02 Certificate of Suitability (COS). The purpose of a NCGC00024995-02 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of NCGC00024995-02 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of NCGC00024995-02 to their clients by showing that a NCGC00024995-02 CEP has been issued for it. The manufacturer submits a NCGC00024995-02 CEP (COS) as part of the market authorization procedure, and it takes on the role of a NCGC00024995-02 CEP holder for the record. Additionally, the data presented in the NCGC00024995-02 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the NCGC00024995-02 DMF.
A NCGC00024995-02 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. NCGC00024995-02 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of NCGC00024995-02 suppliers with CEP (COS) on PharmaCompass.
We have 21 companies offering NCGC00024995-02
Get in contact with the supplier of your choice: